Dr. Speiser did her undergraduate work at Brandeis University, Waltham, MA. She received her MD from Columbia University, The College of Physicians & Surgeons, New York, NY in 1979. Dr. Speiser went on to complete her internship & residency in Pediatrics at The Bronx Municipal Hospital Center, Albert Einstein College of Medicine, Bronx, NY, followed by a research fellowship in Pediatric Endocrinology at Cornell University Medical Center. After two years as a fellow, Dr. Speiser was appointed as assistant professor of Pediatrics in the Department of Pediatrics at Cornell, where she also held the position of assistant program director of the Children’s Clinical Research Center.
Dr. Speiser joined Northwell Health in 1993. In addition to her role at The Feinstein Institutes, she holds the positions of professor of Pediatrics at the Zucker School of Medicine and chief of the Division of Pediatric Endocrinology at Cohen Children’s Medical Center of New York.
Dr. Speiser has had a long-standing interest in congenital adrenal hyperplasia (CAH) and related disorders. She served as Chair of The Endocrine Society Task Force for Clinical Practice Guidelines for CAH and is on the Medical Advisory Boards of The CARES Foundation and the National Adrenal Diseases Foundation. Other clinical research interests include childhood growth, obesity and diabetes. Dr. Speiser has received foundation funding to study the natural history of diabetes risk factors in middle school children as part of a consortium of several metropolitan New York are hospitals, and has participated in TRIALNET, a multicenter diabetes trial sponsored by The National Institutes of Health.
Dr. Speiser is currently involved in an NIH-sponsored multicenter clinical trial to test the safety and efficacy of a novel drug for congenital adrenal hyperplasia in children. Our team is also participating in a study sponsored by Rhythm Pharmaceuticals to identify youngsters with genetic traits predisposing to early onset obesity. Such individuals may qualify for a novel type of drug treatment.
Clinical trial coordinator
Margaret Pellizzari, RN, CDE
Katherine Brunner, RN
Linda Bokor, PNP
Congenital adrenal hyperplasia
Brandeis University, Waltham, Massachusetts
College of Physicians and Surgeons of Columbia University, New York, New York